Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Completed 5Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 5Gastrointestinal 4Other neoplasm 3Genitourinary 3CNS 3Gynecologic 1

Conditions

Skin Neoplasms 2Carcinoma, Basal Cell 2Precancerous Conditions 1Non-melanoma Skin Cancer 1Keratosis, Actinic 1

Interventions

Ipilimumab 123pembrolizumab 101Nivolumab 100aldesleukin 89Cyclophosphamide 85fludarabine phosphate 64Interleukin-2 58Dacarbazine 573-ingenyl angelate 42Vemurafenib 39Temozolomide 39Imiquimod 39trametinib 37sargramostim 37Peripheral Blood Stem Cell Transplantation 36incomplete Freund's adjuvant 35dabrafenib 32fludarabine 31Radiotherapy 31Aminolevulinic Acid 30Bevacizumab 29Carboplatin 28Whole-Body Irradiation 25Photochemotherapy 25Paclitaxel 25Filgrastim 25Biopsy 25Interferon-alpha 24Cisplatin 23Sorafenib 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Eflornithine × Dermatologic × Clear all
NCT04091022 2025-12-17

Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer

University of Alabama at Birmingham

Phase 2 Completed
64 enrolled
Dermatologic

Non-melanoma Skin Cancer

NCT00204789 2019-12-16

Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients

University of Wisconsin, Madison

Phase 2 Completed
52 enrolled
Dermatologic

Skin Neoplasms

NCT00005884 2019-12-13

Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer

University of Wisconsin, Madison

Phase 3 Completed
Dermatologic

Carcinoma, Basal Cell

NCT00021294 2018-09-11

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

University of Arizona

Phase 2 Completed
DermatologicOther neoplasm

Carcinoma, Basal Cell, Precancerous Conditions, Keratosis, Actinic

NCT00601640 2017-03-23

Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin

University of Arizona

Phase 2 Completed
184 enrolled 9 charts
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡